GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aurora Spine Corp (OTCPK:ASAPF) » Definitions » ROCE %

Aurora Spine (Aurora Spine) ROCE % : -11.08% (As of Sep. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Aurora Spine ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aurora Spine's annualized ROCE % for the quarter that ended in Sep. 2023 was -11.08%.


Aurora Spine ROCE % Historical Data

The historical data trend for Aurora Spine's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aurora Spine ROCE % Chart

Aurora Spine Annual Data
Trend Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.86 -23.73 -23.87 -32.52 -17.80

Aurora Spine Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.85 -42.92 -34.93 -24.01 -11.08

Aurora Spine ROCE % Calculation

Aurora Spine's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-1.338/( ( (10.564 - 2.627) + (10.123 - 3.03) )/ 2 )
=-1.338/( (7.937+7.093)/ 2 )
=-1.338/7.515
=-17.80 %

Aurora Spine's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=-0.8/( ( (10.61 - 3.267) + (10.756 - 3.653) )/ 2 )
=-0.8/( ( 7.343 + 7.103 )/ 2 )
=-0.8/7.223
=-11.08 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aurora Spine  (OTCPK:ASAPF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Aurora Spine ROCE % Related Terms

Thank you for viewing the detailed overview of Aurora Spine's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurora Spine (Aurora Spine) Business Description

Traded in Other Exchanges
Address
20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the business of the development and commercialization of minimally invasive interspinous fusion systems and devices. The product portfolio includes implants, surgical tools, and biologics. It derives revenues primarily from the sale of spinal surgery implants, consumable products used in spinal surgeries, and service revenue for referring products to its customers.

Aurora Spine (Aurora Spine) Headlines

From GuruFocus

Aurora Spine Grants Stock Options

By GlobeNewswire 11-17-2023